Search results
Novartis (NVS) Spins off Sandoz, Reiterates Annual Outlook
Zacks via Yahoo Finance· 8 months agoNovartis NVS completed the spin-off of its generic and biosimilar unit, Sandoz, following which...
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo Finance· 11 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
Novartis (NVS) to Report Q1 Earnings: What to Expect?
Zacks via Yahoo Finance· 2 months agoNovartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 23....
Novartis (VTX:NOVN) shareholders have earned a 9.9% CAGR over the last five years
Simply Wall St. via Yahoo Finance· 11 months agoWhen we invest, we're generally looking for stocks that outperform the market average. Buying...
Novartis (NVS) Q2 Earnings Beat, Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoNovartis AG NVS reported mixed second-quarter 2022 results. The Sandoz business continues to recover...
Why Novartis (NVS) Might Surprise This Earnings Season
Zacks via Yahoo Finance· 11 months agoInvestors are always looking for stocks that are poised to beat at earnings season and Novartis AG...
Novartis (NVS) to Report Q2 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 11 months agoWhen Novartis (NVS) reports second-quarter 2023 results, investor focus is likely to be on updates...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
Zacks via Yahoo Finance· 2 months agoNovartis (NVS) announces encouraging data on Fabhalta from a phase III study for the treatment for...
Novartis (NVS) Gets CHMP Positive Opinion for Entresto Approval
Zacks via Yahoo Finance· 1 year agoNovartis NVS announced that its cardiovascular drug Entresto (sacubitril/valsartan) has received a...